Healthtech Offers Investors Big Potential Profits By Preventing Foodborne Illness Outbreaks

Technology and healthcare have always gone together. Which is why as the importance of public health safety increases in tandem with population density, the ‘health tech’ industry is also booming. This is a rapidly growing $6 billion market that has entered its mergers and acquisitions consolidation cycle. And right now, HealthSpace Data Systems Ltd. (CSE:HS) (OTC:HDSLF) (FRA: 38H) is one of the few independent health tech providers left in the entire industry.

Foodborne illnesses are a major threat to public health. In 2017, the CDC launched eight multistate foodborne outbreak investigations, with salmonella and e.coli being the most common. Public health safety is and will continue to be one of the most critical challenges facing our society.  

Technology is stepping up to meet this challenge. One important but little known aspect of healthcare technology is healthcare cloud computing. HealthSpace’s (CSE:HS) (OTC:HDSLF)  (FRA: 38H) flagship software allows organizations to manage apps, permits, licenses, and other business and compliance data through the cloud. This is not only highly customizable, but also very convenient through a single web-based browser interface. Combine this with its sophisticated analytics and monitoring platform, and organizations can turn mere data into useful and actionable insights.

Its mobile product, HealthSpace Touch, allows companies to conduct paperless field inspections. This can even be done while offline, the data is automatically and securely synced after. It’s an ‘all-in-one’ solution for inspection reporting, with applications far beyond just the healthcare field.

Health tech is a huge industry. Frost & Sullivan expects it to almost touch $10 billion by 2021. Transparency Markets International forecasts the industry to be worth $6.8 billion by the end of 2018, with North America accounting for the 72% of the entire market.

‘Whales’ Are Swallowing the Independents

The health tech industry is now entering its consolidation cycle. Independent health tech providers are being snapped up left and right and HealthSpace Data Systems Ltd. (CSE:HS) (OTC:HDSLF) (FRA: 38H) could potentially be the next acquisition target.

In August 2017, Tyler Technologies, Inc. (NYSE:TYL)  acquired health tech company Digital Health Department (“DHD”), a SaaS company focused on environmental health software.. HealthSpace CTO, Silas Garrison, was formerly a senior developer at DHD, and was very instrumental in the development of its initial software.

In 2017 alone, there were over 40 mergers and acquisitions in this space. Here are a couple more prominent examples:

  • NASDAQ-listed HMS Holdings Corp. acquired health engagement platform provider Eliza Corporation for a cash purchase price of $170 million.
  • Welltok Inc., a health enterprise software company acquires analytics company Tea Leaves Health for $83 million.

With such a frenzy of mergers and acquisitions in this industry, it may only be a matter of time before HealthSpace Data Systems Ltd. (CSE:HS)(OTC:HDSLF)(FRA: 38H) gets acquired. The company is a prime acquisition target, and here’s why.

The HealthSpace Advantage – Top Notch Clients Plus Constant Innovation

HealthSpace (CSE:HS) (OTC:HDSLF) (FRA: 38H) may be small, but its clients are giants. Its public sector clientele includes:

  • Health Canada
  • Tennessee Department of Agriculture
  • Tennessee Department of Health
  • Ohio Department of Health
  • Fraser Health Authority
  • Washington State Department of Health
  • Milwaukie Health Department
  • 34 Local Health Departments in Oregon
  • Wisconsin Department of Health Services
  • West Virginia Bureau of Public Health

In total, the company runs 10 statewide programs that touch 23 different states. This is an extraordinary achievement for a company of this size.

But governmental entities aren’t its only clients; the company also offers its SaaS solutions to the hospitality and agriculture industries. In the hospitality industry alone, the company has touched over 200,000 restaurants on the continent and over 14,000 hotels.

HealthSpace Data Systems Ltd. (CSE:HS) (OTC:HDSLF) (FRA: 38H) currently does about $2 million in annual recurring revenue. Over the past three to five years, it has amassed contracts totaling about $10 million.

The clientele that HealthSpace has amassed over the years could potentially make this a steal trading at a $15 million market cap.

Cutting Edge Blockchain Venture Backed by Leading Partnerships

HealthSpace (CSE:HS) (OTC:HDSLF) (FRA: 38H) has a far-sighted management team that recognizes the power and potential of blockchain technology. The company is releasing a blockchain network for decentralizing quality control and safety audits; a ‘blue ocean’ space that has yet to be exploited. The alpha prototype will be released in the first quarter of 2018, and it will test the product with its various industry partners.

Supporting HealthSpace’s (CSE:HS) (OTC:HDSLF) (FRA: 38H) ambitions to integrate blockchain technology into its product offerings are strong partnerships. In December 2017, HealthSpace signed a Letter of Intent with SIMBA Chain Inc., a Blockchain-as-a-Service company. SIMBA Chain is a wholly-owned subsidiary of ITAMCO, and was formed from a DARPA grant to develop a secure and unhackable messaging platform for the US military.

It is currently partnered with the Center for Research Computing at the University of Notre Dame to develop its API. Recently, SIMBA Chain was awarded a contract by a Fortune 500 American multinational chemical company to integrate its API with the company’s ERP systems to use blockchain technology in tracking and logistics.

HealthSpace (CSE:HS) (OTC:HDSLF) (FRA: 38H) has also signed a Memorandum of Understanding with Vanbex Capital, a venture capital firm focusing on blockchain technology. Vanbex Capital has over 60 high growth blockchain companies in its portfolio, including Etherparty, a company focused on providing an easy-to-use smart contract creation tool. HealthSpace will be collaborating with Etherparty to develop its blockchain product, while Vanbex Capital has injected $1 million into HealthSpace via private placement.

Poised for Growth: Positioning Itself for the Recreational Marijuana Boom

In summer 2018, recreational marijuana will be legalized throughout Canada. Deloitte has estimated that this market has a base retail value of $4.9 billion to $8.7 billion annually, with a total economic impact of over $22.6 billion. In America, legal cannabis sales hit $10 billion in 2017 and are expected to hit $24.5 billion by 2021.

HealthSpace has been more than prepared. In August 2017, it signed an MOU with 1804 Management LLC to expand its HealthSpace CS Pro technology to cannabis producers and distributors. HealthSpace will refine its applications for use in the ‘Just-In-Time’ inventories and lean manufacturing processes that power successful cannabis producers.

Combine both blockchain and recreational cannabis with the SaaS model, and you have a company that can not only easily scale, but has already identified new opportunities for growth.

HealthSpace’s Market Cap Is Still Small but It Has Already Shown Impressive Returns

With such a frenzy of mergers and acquisitions in the health tech industry, it’s no surprise that companies have been doing very well. But even in such a booming market, HealthSpace Data Systems Ltd. (CSE:HS) (OTC:HDSLF) (FRA: 38H) stands out. Its stock has doubled in price over the past year, and the best part is that it’s still small and underpriced with a market cap of approximately CAD $17 million.

Tyler Technologies, Inc. (NYSE: TYL)

Market Cap: $7.25 billion

This Texas-based company has seen its stock price on a consistent uptrend over the years. In the past year, its stock has returned an impressive 23%.

Cerner Corporation (NASDAQ: CERN)

Market Cap: $20.38 billion

Based in Kansas, Cerner Corporation is a supplier of health information technology solutions, services, devices, and hardware. Over the past year, its stock returned 16.5% to investors.

Athenahealth, Inc. (NASDAQ: ATHN)

Market Cap: $5.25 billion

Also based in America, Athenahealth provides cloud-based services, including billing and management, to the healthcare industry. Its stock returned about 15% to investors over the past year.

HealthSpace Data Systems Ltd. (CSE:HS) (OTC:HDSLF) (FRA: 38H)

Market Cap: CAD $17 million

Based in Canada and focused on providing leading edge SaaS solutions to healthcare and other industries. While still small, its stock price has delivered 100% returns to investors over the past year.

5 Reasons Investors Should Consider Adding Shares of HealthSpace to Their Portfolio

  • 1
    HealthSpace Is a Prime Acquisition Target – The health tech industry is consolidating, and smaller players with great value propositions are quickly getting snapped up. With HealthSpace’s (CSE:HS) (OTC:HDSLF) (FRA: 38H)
    government contracts, and new technology ventures, coupled with its still small size, could potentially be a prime acquisition target.
  • 2
    Low Market Capitalization – With a market cap of approximately $17 million CAD, HealthSpace is not a large corporation by any measure. With a current stock price of $0.13, HealthSpace is priced at an entry point where investors can potentially earn triple digit profits.
  • 3
    HealthSpace is Constantly Innovating – With an experienced and far-sighted management team and a CTO that developed a product that was acquired by a $7.73 billion dollar giant, HealthSpace (CSE:HS) (OTC:HDSLF) (FRA: 38H) is constantly innovating its product offerings as seen by its foray into blockchain technology and the cannabis industry.
  • 4
    HealthSpace’s Fantastic Client Base – The great thing about SaaS companies is how easy it is to scale their products. HealthSpace, with its stable client base is no different. 100% of their clients have renewed their contracts and it doesn’t look like HealthSpace (CSE:HS) (OTC:HDSLF) (FRA: 38H) will lose a client in the future.
  • 5
    Health Tech Is Only Going to Become More Popular – The health tech industry is projected to grow at almost 20% a year. The amount of healthcare data that needs to be managed will only increase. This is an industry that has huge room for growth, particularly in international markets.


Please See Disclaimer

IMPORTANT NOTICE AND DISCLAIMER: This stock profile should be viewed as a paid advertisement. The publisher, Coinbit Blockchain Solutions Inc., understands that this is an effort to enhance public awareness of HealthSpace Data Systems Ltd. and its securities through the distribution of this advertisement. Coinbit Blockchain Solutions Inc. was paid for this advertorial by Native Ads Inc., in an effort to enhance public awareness of HealthSpace Data Systems Ltd. and its securities. a third party has been retained by HealthSpace Data Systems Ltd. to provide marketing and advertising services. All content, ad creatives and designs were previously approved by HealthSpace Data Systems Ltd. If successful, this advertisement will increase investor and market awareness, which may result in increased numbers of shareholders owning and trading the common stock of HealthSpace Data Systems Ltd., increased trading volumes, and possibly increased share price of the common stock of HealthSpace Data Systems Ltd. This publication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. This publication, its publisher, and its editor do not purport to provide a complete analysis of any company’s financial position. The publisher and editor are not, and do not purport to be, broker-dealers or registered investment advisors. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC filings. Investing in securities, particularly micro cap securities such as HealthSpace Data Systems Ltd. , is speculative and carries a high degree of risk. Past performance does not guarantee future results. This publication is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the publisher cannot guarantee the accuracy or completeness of the information. The publisher conducts little or no due diligence on the profiles that are received by it’s advertisers. The information we disseminate about issuers contain forward looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, projections as indicated by such words as “expects”, “will”, “anticipates”, “estimates”; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation into any such forward looking statements. Forward looking statements are limited to the time period in which they are made and we do not undertake to update forward looking statements that may change at anytime. The publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the company’s actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for the company’s products and services, the company’s ability to fund its capital requirements in the near term and long term and pricing pressures. Many of the penny stocks that are profiled or provide information have low trading volume, which may lead to difficulties in selling your securities. Many penny stocks profiled or provide information about are subject to intense competition, extreme regulatory oversight and inadequate financing to pursue their operational plan. The issuer profiles and information we provide represent only a small or even infinitesimal amount of information regarding the issuer and is insufficient to formulate an investment decision; as such, that information should only be a starting point from which you conduct an in-depth investigation of the issuer from available public sources, such as,,,,, and other available public sources as well as consulting with your financial professional, investment adviser, registered representative with a registered securities broker-dealer. We urge you to conduct an in-depth investigation of the issuer from the above or other available sources, especially because we only present positive information, which is an insufficient basis to invest in any stock, yet alone a penny stock; accordingly, you should proceed with such investigation to determine, among other things, information pertaining to the issuer’s financial condition, operations, business model, and risks involved in the issuer’s business. The issuers we profile may have negative signs on the website (i.e. Stop Sign, No Information, Limited Information, Caveat Emptor), which you should determine from entering the symbol of the stock profiled into the website. You should determine whether the issuer we profile or provide information about is a development stage company, which is subject to the risks of a development stage company in a similar such business, including difficulties in obtaining financing for operations and future growth. You should conduct an investigation of the innumerable risks that are inherent or present in the business plan of almost any penny stock issuer; therefore, do not use our profiles or any information contained in our website or profiles as the sole determination of making an investment decision. We only present positive information regarding an issuer; therefore, you should conduct an in-depth investigation of any possible negative factors regarding such issuer. You should accept our information in an “as is” state; in other words, your use of the information is at your own risk and such information may change at anytime and it is not based upon any verification or due diligence of the statements made. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. Coinbit Blockchain Solutions Inc. and other trademarks and copyrights used in this publication are the property of their respective trademark and copyright holders. Coinbit Blockchain Solutions Inc. is not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by Coinbit Blockchain Solutions Inc. any third-party trademarks or copyrights.

The Article and content related to the profiled company represent the personal and subjective views of the Author of this article, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, Coinbit Blockchain Solutions Inc., Native Ads Inc., or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission, the Canadian Securities Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.